Activity of Lipoprotein-Associated Enzymes in Indigenous Children Living at Different Altitudes

被引:3
|
作者
Hirschler, Valeria [1 ]
Martin, Maximiliano [2 ]
Molinari, Claudia [1 ]
Botta, Eliana [2 ]
Francisco Tetzlaff, Walter [2 ]
Brites, Fernando [2 ]
机构
[1] Univ Buenos Aires, Nutr, Maipu 812, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, CONICET, Sch Pharm & Biochem, Lab Lipids & Athemsclerosis,Dept Clin Biochem, Buenos Aires, DF, Argentina
关键词
Indigenous school children; Paraoxonase; 1; Cholesteryl Transfer Protein; High Altitude; Hypoxia; Oxidative Stress; LIFE-STYLE BEHAVIORS; DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CARDIOMETABOLIC RISK; INVERSE ASSOCIATION; OXIDATIVE STRESS; LEPTIN LEVELS; CHOLESTEROL; OBESITY;
D O I
10.1016/j.arcmed.2019.07.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. High altitude is associated with hypobaric hypoxia, and metabolic modifications. In particular, alterations to lipoprotein-associated enzymes have been reported under hypoxia. Objective. To determine the association between paraoxonase 1 (PON-1) and Cholesteryl-ester transfer protein (CETP) activities and altitude in two groups of Argentinean Indigenous schoolchildren living at different altitudes. Methods. A cross-sectional study compared 151 schoolchildren from San Antonio de los Cobres (SAC), 3,750 m, with 175 schoolchildren from Chicoana (CH), 1,400 m. Anthropometric data, lipids, apolipoprotein (apo) A-I, apo B, plus PON-1 and CETP activities were determined. Results. The prevalence of overweight/obesity was significantly lower in SAC than in CH. Z- BMI (0.3 vs 0.7), Apo A-I/Apo B (1.67 vs. 1.85) and PON-1 (170 vs. 243 nmol/mL.min) were significantly lower in SAC than in CH, respectively. Total cholesterol (156 vs 144 mg/dL), triglycerides (TG) (119 vs. 94 mg/dL), apo A-I (133 vs. 128 mg/dL), apo B (84 vs. 73 mg/dL), hematocrit (48 vs. 41%), transferrin (295 vs. 260 mg/dL) and CETP (181 vs. 150%/mL.h) were significantly higher in SAC than in CH. There was a significant univariate association between altitude and transferrin (r0.38), hematocrit (r0.75), TG (r0.24), apo B (r0.29), PON-1 (r-0.40), and CETP (r0.37). Multiple linear regression analyses showed that altitude was significantly associated with children's TG (beta = 0.28, R-2 = 0.14), HDL-C (beta = 0.27; R-2 = 0.23), apo B (beta = 0.32; R-2 = 0.14), CETP (beta = 0.38; R-2 = 0.15) and PON-1 (beta = -0.36; R-2 = 0.16), adjusted for age, gender and BMI. Conclusion. SAC children presented a more atherogenic lipid profile, plus lower PON1 and higher CETP activities, than CH children. (C) 2019 IMSS. Published by Elsevier Inc.
引用
收藏
页码:98 / 104
页数:7
相关论文
共 50 条
  • [41] Lipoprotein-Associated Phospholipase A2 Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes
    Hatoum, Ida J.
    Hu, Frank B.
    Nelson, Jeanenne J.
    Rimm, Eric B.
    DIABETES, 2010, 59 (05) : 1239 - 1243
  • [42] Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
    Wallentin, Lars
    Held, Claes
    Armstrong, Paul W.
    Cannon, Christopher P.
    Davies, Richard Y.
    Granger, Christopher B.
    Hagstrom, Emil
    Harrington, Robert A.
    Hochman, Judith S.
    Koenig, Wolfgang
    Krug-Gourley, Sue
    Mohler, Emile R., III
    Siegbahn, Agneta
    Tarka, Elizabeth
    Steg, Philippe Gabriel
    Stewart, Ralph A. H.
    Weiss, Robert
    Ostlund, Ollie
    White, Harvey D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [43] Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children
    Ragab, Seham M.
    Safan, Manal A.
    Obeid, Osama M.
    Sherief, Asmaa S.
    HEMATOLOGY, 2015, 20 (04) : 228 - 238
  • [44] Interrelationships among platelet-activating factor and lipoprotein-associated phospholipase A2 activity and traditional cardiovascular risk factors
    English, Carolyn J.
    Lohning, Anna E.
    Mayr, Hannah L.
    Jones, Mark
    Reidlinger, Dianne P.
    BIOFACTORS, 2023, 49 (02) : 457 - 471
  • [45] Hemoglobin Mass, Blood Volume and VO2max of Trained and Untrained Children and Adolescents Living at Different Altitudes
    Mancera-Soto, Erica Mabel
    Ramos-Caballero, Diana Marcela
    Rojas J., Joel A.
    Duque, Lohover
    Chaves-Gomez, Sandra
    Cristancho-Mejia, Edgar
    Schmidt, Walter Franz-Joachim
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [46] Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study
    da Silva, Isis T.
    Timm, Anelise de Souza
    Damasceno, Nagila R. T.
    LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [47] Lipoprotein-associated phospholipase A2 activity and low-density lipoprotein subfractions after a 2-year treatment with atorvastatin in adolescents with type 1 diabetes
    Krebs, Andreas
    Doerfer, Juergen
    Krause, Alexandra
    Grulich-Henn, Juergen
    Holder, Martin
    Hecker, Wolfgang
    Lichte, Kai
    Schmidt-Trucksaess, Arno
    Winkler, Karl
    Schwab, Karl Otfried
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2016, 29 (10) : 1181 - 1186
  • [48] Genome-Wide Association Study Evaluating Lipoprotein-Associated Phospholipase A2 Mass and Activity at Baseline and After Rosuvastatin Therapy
    Chu, Audrey Y.
    Guilianini, Franco
    Grallert, Harald
    Dupuis, Josee
    Ballantyne, Christie M.
    Barratt, Bryan J.
    Nyberg, Fredrik
    Chasman, Daniel I.
    Ridker, Paul M.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2012, 5 (06) : 676 - 685
  • [49] Performance characteristics of lipoprotein-associated phospholipase A2 activity assay on the Dimension Vista analyser and preliminary study of a healthy Italian population
    De Stefano, Alessandro
    Mannucci, Liliana
    Massoud, Renato
    Bernardini, Sergio
    Cortese, Claudio
    BIOCHEMIA MEDICA, 2017, 27 (03) : 492 - 501
  • [50] Lipoprotein-Associated Phospholipase A2 Mass and Activity and Risk of Cardiovascular Disease in a Population With High Prevalences of Obesity and Diabetes The Strong Heart Study
    Kizer, Jorge R.
    Umans, Jason G.
    Zhu, Jianhui
    Devereux, Richard B.
    Wolfert, Robert L.
    Lee, Elisa T.
    Howard, Barbara V.
    DIABETES CARE, 2012, 35 (04) : 840 - 847